BREE PARKER: Open Payments
NPI 1548927726 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$619 in 30 payments from 13 companies in 2025. Trend: 2023 $457 · 2024 $976 · 2025 $619
Food & beverage: $619
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $250 |
| UCB, Inc. | 2 | $75 |
| Surgenex LLC | 3 | $64 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $34 |
| Incyte Corporation | 2 | $32 |
| Janssen Biotech, Inc. | 1 | $30 |
| GENZYME CORPORATION | 1 | $26 |
| Biofrontera Inc. | 1 | $23 |
| Botanix SB Inc | 1 | $23 |
| Sandoz Inc. | 1 | $23 |
Products named: SKYRIZI, Bimzelx, SurGraft, RINVOQ, ILUMYA, OPZELURA, TREMFYA, DUPIXENT.
Industry payments across CA — which companies pay providers there.
